nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACKNOWLEDGMENTS
|
Oesterling, Joseph E. |
|
|
20 |
4 |
p. xvii |
artikel |
2 |
BIOMOLECULAR AND CLINICAL CHARACTERISTICS OF PSA AND OTHER CANDIDATE PROSTATE TUMOR MARKERS
|
Schellhammer, Paul F. |
|
|
20 |
4 |
p. 597-606 |
artikel |
3 |
Contributors
|
|
|
|
20 |
4 |
p. iii-vii |
artikel |
4 |
Copyright Page
|
|
|
|
20 |
4 |
p. ii |
artikel |
5 |
CRAFT OF UROLOGIC SURGERY CUMULATIVE INDEX 1978-1993
|
|
|
|
20 |
4 |
p. 791-794 |
artikel |
6 |
CUMULATIVE INDEX 1993
|
|
|
|
20 |
4 |
p. 779-790 |
artikel |
7 |
DEFINITION OF THE IDEAL TUMOR MARKER
|
Cooner, William H. |
|
|
20 |
4 |
p. 575-579 |
artikel |
8 |
FUTURE DIRECTIONS IN TUMOR MARKER TECHNOLOGY FOR PROSTATE CANCER
|
Smith Jr, Joseph A. |
|
|
20 |
4 |
p. 771-777 |
artikel |
9 |
ISSUES IN THE ASSESSMENT OF PSA IMMUNOASSAYS
|
Vessella, Robert L. |
|
|
20 |
4 |
p. 607-619 |
artikel |
10 |
PREFACE
|
Oesterling, Joseph E. |
|
|
20 |
4 |
p. xv-xvi |
artikel |
11 |
PROSTATIC ACID PHOSPHATASE
|
Romas, Nicholas A. |
|
|
20 |
4 |
p. 581-588 |
artikel |
12 |
PROSTATIC ACID PHOSPHATASE IN 1993
|
Lowe, Franklin C. |
|
|
20 |
4 |
p. 589-595 |
artikel |
13 |
PSA AFTER DEFINITIVE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
|
Goad, Jeremy R. |
|
|
20 |
4 |
p. 727-736 |
artikel |
14 |
PSA AND PAP AS IMMUNOHISTOCHEMICAL MARKERS IN PROSTATE CANCER
|
Epstein, Jonathan I. |
|
|
20 |
4 |
p. 757-770 |
artikel |
15 |
PSA AND STAGING OF LOCALIZED PROSTATE CANCER
|
Kleer, Eduardo |
|
|
20 |
4 |
p. 695-704 |
artikel |
16 |
PSA AS A SCREENING TEST FOR PROSTATE CANCER
|
Crawford, E. David |
|
|
20 |
4 |
p. 637-646 |
artikel |
17 |
PSA DENSITY (PSAD)
|
Seaman, Eric |
|
|
20 |
4 |
p. 653-663 |
artikel |
18 |
PSA-DETECTED (CLINICAL STAGE T1c OR B0) PROSTATE CANCER
|
Oesterling, Joseph E. |
|
|
20 |
4 |
p. 687-693 |
artikel |
19 |
PSA IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC INTRAEPITHELIAL NEOPLASIA
|
Ellis, William J. |
|
|
20 |
4 |
p. 621-625 |
artikel |
20 |
PSA VELOCITY FOR THE DIAGNOSIS OF EARLY PROSTATE CANCER
|
Carter, H. Ballentine |
|
|
20 |
4 |
p. 665-670 |
artikel |
21 |
SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
|
Partin, Alan W. |
|
|
20 |
4 |
p. 713-725 |
artikel |
22 |
SERUM PSA AFTER ANTIANDROGEN THERAPY
|
Petros, John A. |
|
|
20 |
4 |
p. 749-756 |
artikel |
23 |
SERUM PSA AS A TUMOR MARKER FOR PATIENTS UNDERGOING DEFINITIVE RADIATION THERAPY
|
Zagars, Gunar K. |
|
|
20 |
4 |
p. 737-747 |
artikel |
24 |
SIGNIFICANCE OF DIFFERENT MOLECULAR FORMS OF SERUM PSA
|
Lilja, Hans |
|
|
20 |
4 |
p. 681-686 |
artikel |
25 |
Title Page
|
|
|
|
20 |
4 |
p. i |
artikel |
26 |
USING PSA TO ELIMINATE THE STAGING RADIONUCLIDE BONE SCAN
|
Oesterling, Joseph E. |
|
|
20 |
4 |
p. 705-711 |
artikel |
27 |
USING PSA TO SCREEN FOR PROSTATE CANCER
|
Andriole, Gerald L. |
|
|
20 |
4 |
p. 647-651 |
artikel |